X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospectrumasia.com/news/25/24039/cms-and-incyte-collaborate-to-develop-vitiligo-drug-povorcitinib-in-china-and-southeast-asia.html
https://www.fiercebiotech.com/biotech/incyte-itching-piece-dupixents-market-hits-goals-midphase-skin-disease-trial
https://endpts.com/incyte-touts-mid-stage-data-for-new-jak-inhibitor-but-stops-short-of-selecting-phiii-dose/
https://www.businesswire.com/news/home/20230210005205/en/Incyte-Announces-52-Week-Results-from-Phase-2-Study-Evaluating-Povorcitinib-INCB54707-in-Patients-with-Hidradenitis-Suppurativa
Market Place
Share 
